60% by 2030
Growth of radiotherapeutics is expected to continue and will represent 60 percent of the nuclear medicine market by 2030 (MEDraysintell Nuclear Medicine Edition 2017).
To view a full catalog of products that Cardinal Health offers, please use our ordering website.
Looking ahead with the leading minds in healthcare.
Read expert commentary, best practices, and insights from the leaders who are shaping the industry.
Find articles that are relevant to your field of interest.
Take a look at our featured experts who are shaping the healthcare industry.
Learn more about how Cardinal Health is improving healthcare.
We are uniquely committed to nuclear medicine and making investments to support clinical trials of new radiopharmaceuticals that help advance patient care.